Reviewer’ s report
Title: Missed Opportunities to Prevent Cardiovascular Disease in Women with Prior Preeclampsia
Version: 0Date: 13 May 2020
Reviewer's report:For review is an original study examining how often internists inquire about a history of
preeclampsia, as compared to a history of smoking, hypertension and diabetes, when assessing
CVD risk factors at well-woman visits. Current study shows that providers are not adequatelydocumenting obstetric history during well-woman visits and women with history of preeclampsiamight not be identified as having increased CVD risk.
Methods:
1)One limitation of this current study includes sample size.
2)Clinical information about pregnancy complications was collected as mentioned by authors.Have the authors evaluated how often other pregnancy complications such as fetal growthrestriction and preterm delivery were documented versus history of traditional risk factors forCVD?3)Clinical records were obtained by using the Cohort Discovery Tool. Description about this tooland or reference will improve the current manuscript.4)More details about statistical analysis will be needed for better understanding of current data.Define statistical significance on methods section.
Results and discussion:
5)Authors mentioned that use of low-dose aspirin after 12 weeks of gestation is recommended byAGOG and USPSTF for prevention of CVD. Have the authors checked if there is any datarecorded for the current study about use of aspirin?
6)Authors mentioned that lack of statistical significance could be related to the short follow up
time. However, how about the lack of screening? It will be great to identify if providers reallyaccess the education slides and improve the engagement.
Are the methods appropriate and well described?
If not, please specify what is required in your comments to the authors.
YesDoes the work include the necessary controls?
If not, please specify which controls are required in your comments to the authors.
Yes
Are the conclusions drawn adequately supported by the data shown?
If not, please explain in your comments to the authors.
YesAre you able to assess any statistics in the manuscript or would you recommend an
additional statistical review?
If an additional statistical review is recommended, please specify what aspects require further
assessment in your comments to the editors.
I am able to assess the statisticsQuality of written English
Please indicate the quality of language in the manuscript:
AcceptableDeclaration of competing interests
Please complete a declaration of competing interests, considering the following questions:
1. Have you in the past five years received reimbursements, fees, funding, or salary from an
organisation that may in any way gain or lose financially from the publication of thismanuscript, either now or in the future?
2. Do you hold any stocks or shares in an organisation that may in any way gain or lose
financially from the publication of this manuscript, either now or in the future?
3. Do you hold or are you currently applying for any patents relating to the content of the
manuscript?
4. Have you received reimbursements, fees, funding, or salary from an organization that holds
or has applied for patents relating to the content of the manuscript?
5. Do you have any other financial competing interests?6. Do you have any non-financial competing interests in relation to this paper?
If you can answer no to all of the above, write 'I declare that I have no competing interests' below.
If your reply is yes to any, please give details below.
I declare that I have no competing interestsReviewer Publication Consent. I agree for my report to be made available under an Open Access
Creative Commons CC-BY License (http://creativecommons.org/licenses/by/4.0) if this manu-
script is accepted for publication. Any comments that I do not wish to be included in the published
report have been included as confidential comments to the editor, which will not be published.Ifyou are not happy for us to publish this report, please contact the editorial office before completingthe review.If you wish, you can include your name in your published report. Please note you mustdecide whether to include your name at the start of the process and confirm this decision wheneverprompted. If you change your decision later, we will not be able to publish your name.
I agree to the terms of the CC-BY 4.0 license; please do not publish my name with my report.
(default)